Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
2018
Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation
2018
β1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer
2009
Evidence based evaluation of immuno-coagulatory interventions in critical care.
2011
Cancer treatment and survivorship statistics, 2022
2022 Standout
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors
2005
Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients
2012
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
A Visual Stethoscope to Detect the Position of the Tracheal Tube
2009 StandoutNobel
Extracorporeal photochemotherapy for graft versus host disease in pediatric patients
2003
European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators
2010 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
New pharmacotherapy options for chemotherapy-induced alimentary mucositis
2014
Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant–associated thrombotic microangiopathy?
2012
Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP)
2009
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
2002
Ocular Graft-versus-Host Disease: A Review
2013
National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis
2014
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
2010
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
2014
Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
2010
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD
2008
Cancer drug resistance: an evolving paradigm
2013 Standout
Immunoadsorption of factor VIII inhibitors
2004
Intensive extracorporeal photochemotherapy in pediatric patients with chronic graft‐versus‐host disease (cGVHD)
2006
The Immunological Effects of Extracorporeal Photopheresis Unraveled: Induction of Tolerogenic Dendritic Cells In Vitro and Regulatory T Cells In Vivo
2005
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis
2013
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation
2003
Should EMS-paramedics perform paediatric tracheal intubation in the field?
2008
U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease
2008
Characteristics of photopheresis treatments for the management of rejection in heart and lung transplant recipients
2002
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial
2002
Extracorporeal photopheresis for the treatment of refractory Crohnʼs disease: Results of an open-label pilot study
2009
Role of extracorporeal photochemotherapy in patients with refractory chronic graft‐versus‐host disease
2005
TFOS DEWS II pathophysiology report
2017 Standout
Airway techniques and ventilation strategies
2008
Outcomes after major or bidirectional ABO‐mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor‐type secretor plasma with or without plasma exchange
2011
Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation
2011
Chronic graft-versus-host disease
2003 Standout
Understanding and improving low bystander CPR rates: a systematic review of the literature
2008
Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data
2017
Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group
2005
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Using a Laryngeal Tube Suction-Device (LTS-D) Reduces the “No Flow Time” in a Single Rescuer Manikin Study
2009
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients
2012
Photopheresis in pediatric graft‐versus‐host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature
2007
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Graft-versus-host disease
2009 Standout
Pure Red Cell Aplasia After ABO Major‐Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation Successfully Treated with Plasma Exchange and Low‐Dose Steroid: Two Case Reports
2004
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines
2020
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
2003
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Clinical Guide to ABO-Incompatible Allogeneic Stem Cell Transplantation
2013
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD
2011
Vascular endothelial growth factor signaling in acute myeloid leukemia
2012
Extracorporeal photopheresis in acute and chronic graft-versus-host disease
2014
Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies
2014
Interplay between Cortical Spreading Depolarization and Seizures
2017 Standout
Mucositis
2015
Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease
2004
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia
2010
Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy: An Institutional Experience
2018
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
2010
Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies
2007
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
2011
Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study
2011
Part 8: Advanced life support
2010
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
2006
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Serious fungal infections in Canada
2017
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
2017 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion
2004
How do I approach ABO‐incompatible hematopoietic progenitor cell transplantation? (CME)
2011
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy
2013
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Engraftment syndrome following hematopoietic stem cell transplantation
2001
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Emergency intubation for acutely ill and injured patients
2008
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Antichemical Protective Gear Prolongs Time to Successful Airway Management
2004
The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when.
2014
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
European Resuscitation Council Guidelines for Resuscitation 2005
2005
A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation
2008
Streptococcus pneumoniae Infections in 47 Hematopoietic Stem Cell Transplantation Recipients
2007
Gleevec: Prototype or Outlier?
2004 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses.
2005
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
2008
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy
2011
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
2004
Prophylactic red blood cell exchange for ABO ‐mismatched hematopoietic progenitor cell transplants
2013
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies
2009
Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant
2017
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
2003
Current issues in chronic graft-versus-host disease
2014
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
2001
Cancer treatment and survivorship statistics, 2019
2019 Standout
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins
2009
Diagnosis and management of mastocytosis: an emerging challenge in applied hematology
2015
Solid Cancers After Bone Marrow Transplantation
2001
Part 8: Post–Cardiac Arrest Care
2015 Standout
Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T ‐cell lymphoma and chronic graft‐versus‐host disease in a rural hospital
2015
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Identification of Endotracheal Tube Malpositions Using Computerized Analysis of Breath Sounds via Electronic Stethoscopes
2005
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
2005
The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance
2008
Novel therapeutics for the treatment of graft-versus-host disease
2002
Drug Resistance in Cancer: An Overview
2014 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Comparison of Arterial Blood Gases of Laryngeal Mask Airway and Bag-Valve-Mask Ventilation in Out-of-Hospital Cardiac Arrests
2009
Extracorporeal Photopheresis for Steroid Resistant Graft Versus Host Disease in Pediatric Patients
2007
Industry sponsorship and research outcome
2017 Standout
Predictors of Survival From Out-of-Hospital Cardiac Arrest
2009 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients
2013
Multiplex Blood PCR in Combination with Blood Cultures for Improvement of Microbiological Documentation of Infection in Febrile Neutropenia
2010
Nitric Oxide Modulates Spreading Depolarization Threshold in the Human and Rodent Cortex
2008
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of Werner Rabitsch being referenced
The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
2006
Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer
2005
SUCCESSFUL LUNG TRANSPLANTATION FOR BRONCHIOLITIS OBLITERANS AFTER ALLOGENEIC MARROW TRANSPLANTATION
2001
Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients
2008
Comparison of a conventional tracheal airway with the Combitube in an urban emergency medical services system run by physicians
2003
Frequency and prognostic value of D alloantibodies after D‐mismatched allogeneic hematopoietic stem cell transplantation after reduced‐intensity conditioning
2011
Bone Marrow Microvessel Density and it's Prognostic Significance in AML
2004
RAPID ESTABLISHMENT OF LONG-TERM CULTURE-INITIATING CELLS OF DONOR ORIGIN AFTER NONMYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION, AND SIGNIFICANT PROGNOSTIC IMPACT OF DONOR T-CELL CHIMERISM ON STABLE ENGRAFTMENT AND PROGRESSION-FREE SURVIVAL
2003
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden
2012
Regeneration of erythropoiesis after related‐ and unrelated‐donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems
2000
Influence of inhaled nitric oxide on plasma nitrate concentrations in patients with adult respiratory distress syndrome and sepsis: results of a pilot study
2006
Evaluation of an end-tidal portable ETCO2 colorimetric breath indicator (COLIBRI)
2004
In vitro activity of daptomycin and tigecycline against coagulase‐negative staphylococcus blood isolates from bone marrow transplant recipients
2007
ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: Close association with transplant-associated microangiopathy
2007
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption
2003
Streptococcus pneumoniae mycotic aortic aneurysm after allogeneic bone marrow transplantation
2002
Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support
1998
Evaluation of the oesophageal-tracheal double-lumen tube (Combitube) during general anaesthesia
2004
Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia
1999
Removal of persisting isohaemagglutinins with Ig-Therasorb(R) immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation
2003
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
2010
Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
2015
Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD)
1999
Effectiveness of mouth-to-mouth resuscitation performed by young adolescents on a mannequin
2005
ENERGY AND SUBSTRATE METABOLISM IN PATIENTS WITH CHRONIC EXTENSIVE GRAFT-VERSUS-HOST DISEASE
2001
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT
2008
Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO‐mismatched allogeneic peripheral blood progenitor cell transplantation after reduced‐intensity conditioning
2007
Randomized Controlled Trial of Two Different Dosing Regimens of Palifermin to Prevent Mucositis In Multiple Myeloma Patients Receiving One-Day Administration of High-Dose Melphalan
2010
Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group
2008
Successful Use of Extracorporeal Photochemotherapy in the Treatment of Severe Acute and Chronic Graft-Versus-Host Disease
1998
Diverse T Cell Responses Lead To The Different Manifestations Of Cutaneous Graft-Versus-Host Disease
2013
Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease
2013
Successful Use of Extracorporeal Photochemotherapy in the Treatment of Severe Acute and Chronic Graft-Versus-Host Disease
1998